AIP
ALPN

Ameritas Investment Partners’s Alpine Immune Sciences Inc ALPN Stock Holding History

Ameritas Investment Partners’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,835
Closed -$152K – 3285
2024
Q1 		$152K Buy
3,835
+464
+14% +$13.7K 0.01% 1478
2023
Q4 		$64.3K Buy
3,371
+750
+29% +$10.4K ﹤0.01% 2019
2023
Q3 		$30K Hold
2,621
– – ﹤0.01% 2352
2023
Q2 		$26.9K Buy
2,621
+721
+38% +$6.5K ﹤0.01% 2404
2023
Q1 		$14.7K Buy
1,900
+989
+109% +$7.88K ﹤0.01% 2572
2022
Q4 		$7.49K Hold
911
– – ﹤0.01% 2866
2022
Q3 		$6K Hold
911
– – ﹤0.01% 2909
2022
Q2 		$7K Hold
911
– – ﹤0.01% 2924
2022
Q1 		$8K Hold
911
– – ﹤0.01% 2870
2021
Q4 		$13K Hold
911
– – ﹤0.01% 2829
2021
Q3 		$10K Hold
911
– – ﹤0.01% 2949
2021
Q2 		$8K Buy
+911
New +$9.9K ﹤0.01% 2964

Ameritas Investment Partners's ALPN Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 3,835 shares — an estimated $152K sold.

Ameritas Investment Partners first reported a position in ALPN in Q2 2021 and held it in 12 quarters. The position peaked at $152K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Ameritas Investment Partners reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,835 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $152K.
  • Ameritas Investment Partners first reported a position in Alpine Immune Sciences Inc in Q2 2021 and held it in 12 quarters.
  • Ameritas Investment Partners's Alpine Immune Sciences Inc position peaked at $152K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.